NEWS
BioMarin Strengthens Enzyme Therapy Business with Acquisition of Inozyme Pharma
PRNewswire
2025/05/16BioMarin Strengthens Enzyme Therapy Business with Acquisition of Inozyme Pharma
BioMarin Pharmaceutical logo (PRNewsfoto/BioMarin Pharmaceutical Inc.)
Inozyme Pharma, Inc.
Summary
/PRNewswire/ -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) and Inozyme Pharma, Inc. (Nasdaq: INZY) announced today that BioMarin has entered into a definitive...